Professor Mark Hutchinson

Professor Mark Hutchinson
 Position Director - Centre for Nanoscale BioPhotonics
 Org Unit Medical Sciences
 Telephone +61 8 8313 0322
 Mobile +61 4 6630 4980
 Location Floor/Room 3 10 ,  The Braggs ,   North Terrace
  • Biography/ Background

    Professor Hutchinson is a Professor within the Adelaide Medical School and is the Director of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP;

    Professor Hutchinson returned to the University of Adelaide in 2009 as an NHMRC CJ Martin Research Fellow, and established the Neuroimmunopharmacology research laboratory. From 2005 to 2009 Mark worked in the world leading laboratory of Prof Linda Watkins in the Center for Neuroscience at the University of Colorado at Boulder. Here he pioneered with Prof Watkins the research which has led to the discovery of novel drug activity at innate immune receptors.

    Mark’s research has implicated the brain immune-like cells in the action of drugs of dependence and the negative side effects of pain treatments.

    Mark has published over 130 papers in journals and refereed conference proceedings.

    The CNBP is an ARC Centre of Excellence with $42M of funding committed for 7 years, headquartered at The University of Adelaide, with nodes at Macquarie University, Sydney and the RMIT, Melbourne. We are partnered with universities and companies in Europe, the US and China, as well as other  Australian institutions.  

    The CNBP has a mission to "Discover new approaches to measure nano-scale  dynamic phenomena in living systems".  

    The Scientific Aims of the CNBP are to:  

    1. Reach the limits of light-based measurement within complex and dynamic  biological environments;  

    2. Exploit physics and multiple scales -- nanoscale to macro -- using  photons to bridge from nanomaterial to devices;  

    3. Create smart, tailored interfaces between these nanoscale systems and  the biochemical environment;  

    4. Establish new forms of measurement assays that can operate within  living organisms;

    5. Deploy these assays to address identified challenges in systems  including the embryo, brain and blood vessels; and  

    6. Seek molecular level insight into the mechanisms, processes and functionalities in these biological systems.  


  • Qualifications

    PhD in Medicine, University of Adelaide, 2004

    BSc (First class Honours) in Pharmacology, University of Adelaide, 1999

  • Awards & Achievements

    Elsevier Brain Behavior & Immunity Reviewer of the Year (2014)

    South Australian Leading Light Finalist (2013)

    Psychoneuroimmunology Research Society Robert Ader New Investigator Award (2013)

    Scopus Young Researcher Award Finalist (2012)

    Australian Pain Society Tess Cramond Lecturer (2012)

    College on Problems of Drug Abuse Early Career Prize (2011)

    South Australian Tall Poppy Science Awardee (2010)

    Denis Wade Johnson & Johnson New Investigators Award (2009)

    National Institute for Drug Addiction Young Investigator Award (2007)

    Society on Neuroimmune Pharmacology Travel Award (2006)

    Front Range Neuroscience Group Oral Presentation Finalist Winner (2005)

    Front Range Neuroscience Group Oral Presentation Finalist Winner (2005)

    American Australian Association Merck Company Foundation Fellow (2005)

    Front Range Neuroscience Group Chapter travel award nomination (2005)

    Front Range Neuroscience Group Chapter oral presentation winner (2005)

    Recipient of a British Council Travel Award (2005)

    Australian FreshScience Winner (2004)

  • Publications

  • Professional Associations

    Society for Neuroscience

    Australian Neuroscience Society

    Psychneuroimmunology Research Society (PNIRS)

    Australasian Society of Clinical & Experimental Pharmacology & Toxicology

    International Association for the Study of Pain

    American Pain Association 

    American Australian Association

    British Council – Australia

  • Media Expertise

    CategoriesMedicine & Medical Research, Drugs
    ExpertiseNeuroscience; Immunology; Pharmacology; Drug Addiction; Microglia; Cytokine; Chemokine; Pain; Reward; Opioid; Opiate; Alcoholism; Immunogenetics; Toll Like Receptor; Astrocyte; Drug Abuse; Glia; Inflammation; Drug Development; Analgesia; Pain killer; biophotonics; collaboration; science governance;
    NotesProfessor Hutchinson is the Director of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) and a Professor within the School of Medicine at the University of Adelaide.
    After hours0466304980

The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.

Entry last updated: Sunday, 20 Sep 2020

To link to this page, please use the following URL: